Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AML

R K Malladi, A J Peniket, T J Littlewood, K E Towlson, R Pearce, J Yin, J D Cavenagh, Charles Craddock, K H Orchard, E Olavarria, G McQuaker, M Collin, D I Marks, British Society of Blood and Marrow Transplantation

Research output: Contribution to journal › Article › peer-review

19 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AML'. Together they form a unique fingerprint.

Medicine & Life Sciences